AUTOLUS THERAPEUTICS WKN: A2JNZJ ISIN: US05280R1005 Kürzel: AUTL Forum: Aktien Thema: Hauptdiskussion

Markt Kap 366 Millionen und behalten sich vor fast noch mal so viel zu verwässern. Habe ich das richtig verstanden

Kein Wunder wenn der Kurs so runter geht

Wie weit geht es denn noch in den keller?

Hier ist Auch keiner mehr. Alle geschockt oder raus?

Mehr als 50% tiefer als vor Zulassung

Es verkauft doch keiner bei so einem Kurs

Sind das shorter

Scheinbar. Aber ich verstehe nicht warum?

Geht es hier dem Ende entgegen???

was bedeutet das auf deutsch

😱

Der Grund ist die Pflichtverordnung zu sec 8 Beschaffung von Kapitel sieht die Börse immer skeptisch 😉300,000,000 Ordinary Shares American Depositary Shares representing Ordinary Shares Debt Securities Warrants This prospectus will allow us to issue, from time to time at prices and on terms to be determined at or prior to the time of the offering, any combination of the securities described in this prospectus and any prospectus supplement, either individually or in units. We may also offer American Depositary Shares, or ADSs, representing ordinary shares upon conversion of or exchange for the debt securities or upon the exercise of the warrants. The aggregate initial offering price of the securities that we may offer and sell under this prospectus will not exceed $300,000,000. This prospectus describes the general terms of these securities and the general manner in which these securities will be offered. We will provide you with the specific terms of any offering in one or more supplements to this prospectus. The prospectus supplements will also describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained in this document. You should read this prospectus and any prospectus supplement, as well as any documents incorporated by reference into this prospectus or any prospectus supplement, carefully before you invest. Our securities may be sold directly by us to you, through agents designated from time to time or to or through underwriters or dealers. For additional information on the methods of sale, you should refer to the section titled “Plan of Distribution” in this prospectus and in the applicable prospectus supplement. If any underwriters or agents are involved in the sale of our securities with respect to which this prospectus is being delivered, the names of such underwriters or agents and any applicable fees, commissions or discounts and over-allotment options will be set forth in a prospectus supplement. The price to the public of such securities and the net proceeds that we expect to receive from such sale will also be set forth in a prospectus supplement. Our ADSs are traded on the Nasdaq Global Select Market, or Nasdaq, under the symbol “AUTL.” On March 19, 2025, the closing sale price of